Results 181 to 190 of about 13,238 (216)
Safety and immunogenicity of a first-generation modified vaccinia virus Ankara-vectored SARS-CoV-2 vaccine candidate with mRNA-based booster vaccination: A phase 1 trial. [PDF]
Fathi A +17 more
europepmc +1 more source
Wearable Technologies for Vaccines and Therapeutics in Infectious Diseases: A Scoping Review
Shahmoon E, Nemet D, Yamin D.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Vaccine Injection Technique and Reactogenicity—Evidence for Practice
Vaccine, 2008There are inconsistencies in recommendations and practice with regards to how best to administer vaccines. This review evaluates the literature on intramuscular vaccine administration technique in primarily paediatric populations and concludes from available evidence which aspects of vaccine administration are associated with reactogenicity.
Helen Petousis-Harris
exaly +3 more sources
Adjuvants like AS01B increase the immunogenicity of vaccines and generally cause increased transient reactogenicity compared with Alum. A phase II randomized trial was conducted to characterize the response to AS01B and Alum adjuvanted vaccines.
Wivine Burny +2 more
exaly +2 more sources
Reactogenicity and immunogenicity of inactivated hepatitis A vaccines
Vaccine, 1992Two inactivated hepatitis A virus (HAV) candidate vaccine strain were tested, derived from strains CLF and HM175. Neither vaccine increased liver enzymes levels and reactogenicity was similar to that observed with other alum-absorbed products. Antibody responses were dose-dependent and protection against HAV can be presumed to last for at least three ...
Just M, Berger R
openaire +3 more sources
Immunogenicity and reactogenicity of new multivalent pneumococcal vaccines
Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale. A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie, 1982In a study conducted in two phases at one month's interval, 22 healthy adult volunteers received a tetravalent (1, 3, 4, 12F) polysaccharide pneumococcal vaccine; 21 other subjects received another tetravalent (14, 18C, 19F, 23F) vaccine and 25 received a pentadecavalent vaccine (1, 3, 4, 6A, 7F, 8, 9N, 11A, 12F, 14, 15F, 18C, 19F, 23F).
G, Wiedermann +4 more
openaire +2 more sources
REACTOGENICITY TRENDS BY AGE TO INFLUENZA AND PNEUMOCOCCAL VACCINES
Journal of the American Geriatrics Society, 2005Authors replicate about an experience of vaccination that involved 320 individuals aged 65 and older attending one hospital geriatric unit, with the results of a study performed on 29,086 persons aged 65 and older (mean age 74.6, range 65–102) during the fall of 1999 in association with the Sicilian Region Public Health Authorities.
D'Alessandro, Daniela +3 more
openaire +2 more sources
Reactogenicity, the occurrence of vaccine side effects, can impact vaccine acceptance. There is limited data comparing the reactogenicity of COVID-19 vaccines to other routinely used vaccines, such as the meningococcal conjugate vaccine (MenACWY).
Xinxue Liu, Hadi Beyhaghi, Saul N Faust
exaly +2 more sources
Reactogenicity and immunogenicity of a double-strength acellular pertussis vaccine
Vaccine, 1992The reactogenicity and immunogenicity of a double-strength acellular pertussis vaccine were evaluated after administration to 16 4-6-year-old children. The vaccine contained toxoided lymphocytosis-promoting factor (6.0 micrograms/dose), filamentous haemagglutinin (70 micrograms/dose), agglutinogens (1.4 micrograms/dose) and the 69 kDa protein ...
D A, Blumberg +9 more
openaire +2 more sources

